openPR Logo
Press release

Stellar Innovation to drive the Compounding Pharmacies Market

12-10-2021 10:40 AM CET | Health & Medicine

Press release from: Persistence Market Research

Stellar Innovation to drive the Compounding Pharmacies Market

The Compounding Pharmacies Market is likely to mark stellar growth in the upcoming period. The current situation calls for conducive integrated healthcare models that do away with middlemen regarding offering various products and services. Drug manufacturers, hospital systems, PBMs (pharmacy benefit managers), wholesale distributors, hospital systems, medical insurers, and retail pharmacy outlets – are all into the integration of healthcare strategies. This would be how the healthcare vertical function in the upcoming period.

As per Persistence Market Research’s latest revised industry analysis, the global compounding pharmacies market is expected to witness high growth from US$ 8.9 Bn in 2020 to around US$ 21.3 Bn by 2031. This reflects a CAGR of around 8.3% over the forecast period (2021-2031).

To remain ‘ahead’ of your competitors, request for a sample @ https://www.persistencemarketresearch.com/samples/5270

Increasing number of patients visiting physicians to seek medical attention for chronic conditions and high need for prescription medications are resulting in an expanding global market for compounding pharmacies. Compounded pharmacists provide customized medications to patients who cannot acquire outcomes from taking commercially accessible pharmaceuticals. Demand for customized hormone replacement therapies have increased in the recent past as people have become more conscious about important health functions such as breast and bone health, erectile longevity, osteoporosis, mood swings, hot flashes, acute levels of depression, etc.

Accordingly, dosage requirements for specific customized solutions driven demand for hormones such as progesterone after hysterectomy, testosterone replacement, infertility curing hormones, etc. These therapies are expensive and in high demand, owing to rapid growth of lifestyle-related diseases in the young population due to lifestyle changes and increasing stress levels.

Key players are focusing on strengthening their position by collaborating with local manufacturers and acquisitions to enhance their sales. Moreover, companies are targeting North America, Asia Pacific, and Europe through the adoption of research & development and partnerships in the market.

In November 2020, B. Braun Melsungen AG and Grifols formed a strategic partnership to enhance compounding pharmacy production output and services for hospitals. Grifols is a leading producer of plasma-derived medicines and has compounding centres across the U.S.
In February 2016, PharMEDium Services, LLC announced a sole source agreement with Premier, Inc. to provide a wide range of services used for pain management, operating room anaesthesia, intensive care, nerve block, and labour and delivery.

Such developments not only strengthen a company’s existing portfolio but also help increase its presence at regional as well as global levels.

Company Profiles:

Fagron
Fresenius Kabi AG
PharMEDium Services LLC
Institutional Pharmacy Solutions
Cantrell Drug Company
Lorraine’s Pharmacy
B. Braun Melsungen AG Company

Get a Customized Scope to Match Your Need Ask an Expert- sales@persistencemarketresearch.com

Key Takeaways from Market Study

By product, oral medication is set to hold a high share of 43.5% in 2021, expanding at 9.6% CAGR during the forecast period.
By application, medication for adults will hold a high share of 53.3% in 2021, expanding at 9.5% CAGR during the forecast period.
In terms of therapeutic area, hormone replacement therapy accounts for 63.5% market share in 2021.
By region, North America held the largest share of 66.3% in 2021, due to emergence of new compounding pharmacies in North America to meet growing need for specialized care and hard drugs.

“Rising medicinal droughts in required medication levels across the world, increasing cost of branded prescription equivalents, and inadequate accessibility to drugs are expected to drive demand for compounding pharmacies,” says an analyst of Persistence Market Research.

For critical insights, request for methodology @ https://www.persistencemarketresearch.com/methodology/5270

Who is Winning?

Some of the leading manufacturers of compounding pharmacies are focusing on product approvals, acquisitions, mergers, collaborations, and partnerships for global expansion objectives, thereby enhancing their market presence.

On May 27, 2020, the US FDA accepted for review Fresenius Kabi’s first biosimilar regulatory submission for MSB11455, a biosimilar candidate of pegfilgrastim.
In April 2018, Fagron acquired Humco, a developer, manufacturer, and supplier of patented delivery vehicles and branded pharmaceutical products in the U.S.
In September 2015, Lorraine’s Pharmacy received funds worth US$ 53.9 Mn from the U.S. government in order to get FDA approval for its product ReCell, an autologous cell harvesting device.
In mid-2015, Fagron merged with AnazaoHealth Corporation, which specializes in nuclear, pain, and intrathecal customized medication.

Key market players covered in the research by Persistence Market Research include Fagron, Fresenius Kabi AG, PharMEDium Services, LLC, Institutional Pharmacy Solutions, Cantrell Drug Company, Lorraine’s Pharmacy, and B. Braun Melsungen AG Company.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the compounding pharmacies in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The study provides compelling insights into compounding pharmacies market. The market is segmented into product (oral medication (capsules, tablets, mixtures, lollipops, lozenges), topical medication (gels, ointments, cream, lotions, mouthwashes, and suppositories)), application (medication for adults, medication for veterinary, medication for children, and medication for geriatric), and therapeutic area (pain management and hormone replacement therapy), across five major regions of the world.

For in-depth competitive analysis, buy now @ https://www.persistencemarketresearch.com/checkout/5270

Company Profiles: https://www.persistencemarketresearch.com/market-research/compounding-pharmacies-market.asp

Contact us:
305 Broadway, 7th Floor
New York City, NY 10007 United States
Ph.no. +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com

About us-
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stellar Innovation to drive the Compounding Pharmacies Market here

News-ID: 2493237 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for Pharmacy

Pharmacy Automation Systems Market Analysis By Top Keyplayers - Inpatient Pharma …
The "Pharmacy Automation Systems Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Pharmacy Automation Systems Market, 2024-2031 Verified Market Research's most recent report, "Pharmacy Automation Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides
Convenient and reliable online pharmacy - Onlinepills pharmacy
Onlinepills Pharmacy is a trusted and reliable online pharmaceutical company that has been serving the global community for over a decade. Onlinepills Pharmacy ensures and prioritizes customer interest with premium customer assistance and the best offers on prescription medicines. Key Benefits at Onlinepills Pharmacy: • No prescriptions are asked to order medicines. • Genuine medicines at the best price. • Medicines undergo quality checks before shipping in discreet and safe packages. • Tracking details are provided after shipping
Pharmacy Compounding For Veterinary Medicine Market Next Big Thing | Medisca, Lo …
Worldwide Pharmacy Compounding For Veterinary Medicine Market In-depth Research Report 2021, Forecast to 2026 is the latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities, and leveraging with strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Worldwide Pharmacy Compounding For Veterinary Medicine Market. Some of the key players
Compounding Pharmacy Market Competitive Outlook Covering COVID-19 Impact | Lorra …
The role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs in the market. Compounded drugs are the amalgamation of two or more drug ingredients in different proportions, i.e., combining or altering the active pharmaceutical ingredients of drugs to meet the unmet medical need of an individual patient. The major driver of compounding pharmacies market is
Compounding Pharmacy Market SWOT Analysis by Key Players: Olympia Pharmacy, Wedg …
Latest Market intelligence report released by HTF MI with title "Global Compounding Pharmacy Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)" is designed covering micro level of analysis by manufacturers and key business segments. The Global Compounding Pharmacy Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is